These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6571182

  • 1. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
    Kondás J, Szentgyörgyi E.
    Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182
    [No Abstract] [Full Text] [Related]

  • 2. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
    Zárandy B, Szabó J, Molnár I, Sallai Z, Simon Z, Légrády J.
    Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
    [Abstract] [Full Text] [Related]

  • 3. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP.
    Prog Clin Biol Res; 1992 Oct; 378():95-101. PubMed ID: 1301591
    [No Abstract] [Full Text] [Related]

  • 4. The use of intravesical chemotherapy and possibilities for improving its efficacy.
    Sylvester RJ.
    Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
    [No Abstract] [Full Text] [Related]

  • 5. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R.
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of low and high risk superficial bladder tumors (SBT).
    Rübben H, Deutz FJ, Hofstädter F, Meyers W.
    Prog Clin Biol Res; 1990 Aug; 350():61-70. PubMed ID: 2385610
    [No Abstract] [Full Text] [Related]

  • 8. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR, Kopp J.
    Prog Clin Biol Res; 1984 Aug; 162B():397-427. PubMed ID: 6438644
    [No Abstract] [Full Text] [Related]

  • 9. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
    Ayres BE, Crew JP, Action for Bladder Cancer.
    BJU Int; 2010 Feb; 105 Suppl 2():14-7. PubMed ID: 20089093
    [No Abstract] [Full Text] [Related]

  • 10. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1988 Feb; 12(5):419-23. PubMed ID: 3218579
    [No Abstract] [Full Text] [Related]

  • 11. The place of intravesical chemotherapy as defined by results of prospective randomized studies (substances and treatment schemes).
    Lamm DL, Griffith JG.
    Prog Clin Biol Res; 1992 Feb; 378():43-53. PubMed ID: 1301585
    [No Abstract] [Full Text] [Related]

  • 12. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Feb; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 13. Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection?
    Dobruch J, Herr H.
    BJU Int; 2009 Jul; 104(2):170-4. PubMed ID: 19493266
    [No Abstract] [Full Text] [Related]

  • 14. Improving efficacy of intravesical chemotherapy.
    Gasión JP, Cruz JF.
    Eur Urol; 2006 Aug; 50(2):225-34. PubMed ID: 16793196
    [Abstract] [Full Text] [Related]

  • 15. [The preventive recurrent results of postoperative intravesical instillation therapy in bladder cancer].
    Zhang S, Li H, Cheng H.
    Zhonghua Wai Ke Za Zhi; 1995 May; 33(5):304-6. PubMed ID: 7587700
    [Abstract] [Full Text] [Related]

  • 16. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Jalón Monzón A, Martínez Gómez FJ, Sánchez Trilla A, Regadera Sejas J.
    Arch Esp Urol; 2007 May; 60(1):36-43. PubMed ID: 17408170
    [Abstract] [Full Text] [Related]

  • 17. Intravesical chemotherapy--other agents.
    Smith PH, Cruickshank J, Hetherington JW.
    Prog Clin Biol Res; 1984 May; 162B():173-9. PubMed ID: 6504895
    [No Abstract] [Full Text] [Related]

  • 18. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 19. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG].
    Wetzel O, Glemain P, Bouchot O, Guillonneau B, Baron M, Buzelin JM, Auvigne J.
    Prog Urol; 1993 Mar; 3(4):595-607. PubMed ID: 8401620
    [Abstract] [Full Text] [Related]

  • 20. Superficial bladder cancer--problems with selection.
    Glashan RW.
    Prog Clin Biol Res; 1985 Mar; 185B():13-8. PubMed ID: 4034586
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.